Gene linked with successful hypertension therapy:
This article was originally published in Clinica
Individuals with high blood pressure who have a particular variant of the adducin gene are twice as likely to avoid heart attacks and strokes if they take a diuretic medication, says a US research team. Screening for the Gly460Trp variant of the adducin gene, which affects the way in which the kidneys deal with salt and water balance, could help identify those especially likely to benefit for low-dose diuresis, report University of Washington researchers in The Journal of the American Medical Association (April 3).
You may also be interested in...
Data show Opdivo/Cabometyx combo bests Sutent for overall and progression-free survival and response endpoints in first-line RCC. Exelixis CEO says comparison to Sutent is standard control and allows better comparison to other combo regimens.
ES: Public Company Edition: Fifty biopharma companies launched initial public offerings in the US last year and there have been 52 so far in 2020, including Metacrine, Dyne, Athira and COMPASS.
In an update to stakeholders, the US FDA says regulators can successfully evaluate a firm’s performance, allowing it to eventually get medical software to market in the agency’s Pre-Cert Program.